Major Program
              NCI Community Oncology Research Program
                    Research Group
              Community Oncology and Prevention Trials
                    Sponsor
                    SWOG Cancer Research Network
                Status
                    Active, not recruiting
                NCT ID
                    NCT04435756
                This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.
            
  
  
      Intervention
                    Biomarker Analysis, Blood Product Collection
                Condition
                    Germ Cell Tumor, Metachronous Malignant Neoplasm, Seminoma, Stage I Testicular Cancer AJCC V8, Stage IA Testicular Cancer AJCC V8, Stage IB Testicular Cancer AJCC V8, Stage is Testicular Cancer AJCC V8
                Investigators
                    Craig R Nichols
                